LLC (“Precision”) as the clinical research organization (“CRO”) to conduct the European component of the upcoming registrational Phase 3 study of eRapa in FAP. The U.S. component of the study will be ...

LLC (“Precision”) as the clinical research organization (“CRO”) to conduct the European component of the upcoming registrational Phase 3 study of eRapa in FAP. The U.S. component of the ...

Biodexa Announces Appointment of Precision for Medicine LLC as CRO for European Component of Phase 3 Study of eRapa in FAP Biodexa is finalizing plans to initiate an international Phase 3 ...

The planned registrational Phase 3 study of eRapa in FAP will be a double-blind placebo-controlled trial in 168 patients, randomized 2:1 drug / placebo. It is expected the study will be conducted in ...

Go to: All | SP | RP | C | 1B | 2B | 3B | SS | OF | DH Outlook: Hoffman essentially matched the numbers from his 2023 breakthrough over a full season as a 2024 All-Star. He actually would have ...

Hoffman was on the Foul Territory podcast this morning talking about his upcoming first season back with the Blue Jays, the very team that drafted him years ago. New Blue Jays reliever Jeff Hoffman ...

Hoffman said shortly after he signed his three-year, $33 million US deal to return to the team that selected him ninth overall in the 2014 draft. -Longley Blue Jays pitcher Jeff Hoffman speaks on his ...

Toronto Blue Jays offseason acquisition Jeff Hoffman benefited from some excellent defence and picked up a strikeout in his spring training debut with the club that drafted him almost 11 years ago.

DUNEDIN, Fla. – As Jeff Hoffman took the mound at TD Ballpark for his Grapefruit League debut earlier this week, he felt a sense of déjà vu. “I came to the realization that when I first ...